Genetic polymorphisms in CYP2E1: association with schizophrenia susceptibility and risperidone response in the Chinese Han population.

CYP2E1 is a member of the cytochrome P450 superfamily, which is involved in the metabolism and activation of both endobiotics and xenobiotics. The genetic polymorphisms of CYP2E1 gene (Chromosome 10q26.3, Accession Number NC_000010.10) are reported to be related to the development of several mental...

Full description

Bibliographic Details
Main Authors: Ran Huo, Kefu Tang, Zhiyun Wei, Lu Shen, Yuyu Xiong, Xi Wu, Jiamin Niu, Xia Han, Zhengan Tian, Lun Yang, Guoyin Feng, Lin He, Shengying Qin
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2012-01-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC3350493?pdf=render
id doaj-f94b55e3789746cd882692eafc742633
record_format Article
spelling doaj-f94b55e3789746cd882692eafc7426332020-11-25T02:33:37ZengPublic Library of Science (PLoS)PLoS ONE1932-62032012-01-0175e3480910.1371/journal.pone.0034809Genetic polymorphisms in CYP2E1: association with schizophrenia susceptibility and risperidone response in the Chinese Han population.Ran HuoKefu TangZhiyun WeiLu ShenYuyu XiongXi WuJiamin NiuXia HanZhengan TianLun YangGuoyin FengLin HeShengying QinCYP2E1 is a member of the cytochrome P450 superfamily, which is involved in the metabolism and activation of both endobiotics and xenobiotics. The genetic polymorphisms of CYP2E1 gene (Chromosome 10q26.3, Accession Number NC_000010.10) are reported to be related to the development of several mental diseases and to be involved in the clinical efficacy of some psychiatric medications. We investigated the possible association of CYP2E1 polymorphisms with susceptibility to schizophrenia in the Chinese Han Population as well as the relationship with response to risperidone in schizophrenia patients.In a case-control study, we identified 11 polymorphisms in the 5' flanking region of CYP2E1 in 228 schizophrenia patients and 384 healthy controls of Chinese Han origin. From among the cases, we chose 130 patients who had undergone 8 weeks of risperidone monotherapy to examine the relationship between their response to risperidone and CYP2E1 polymorphisms. Clinical efficacy was assessed using the Brief Psychiatric Rating Scale (BPRS).Statistically significant differences in allele or genotype frequencies were found between cases and controls at rs8192766 (genotype p = 0.0048, permutation p = 0.0483) and rs2070673 (allele: p = 0.0018, permutation p = 0.0199, OR = 1.4528 95%CI = 1.1487-1.8374; genotype: p = 0.0020, permutation p = 0.0225). In addition, a GTCAC haplotype containing 5 SNPs (rs3813867, rs2031920, rs2031921, rs3813870 and rs2031922) was observed to be significantly associated with schizophrenia (p = 7.47E-12, permutation p<0.0001). However, no association was found between CYP2E1 polymorphisms/haplotypes and risperidone response.Our results suggest that CYP2E1 may be a potential risk gene for schizophrenia in the Chinese Han population. However, polymorphisms of the CYP2E1 gene may not contribute significantly to individual differences in the therapeutic efficacy of risperidone. Further studies in larger groups are warranted to confirm our results.http://europepmc.org/articles/PMC3350493?pdf=render
collection DOAJ
language English
format Article
sources DOAJ
author Ran Huo
Kefu Tang
Zhiyun Wei
Lu Shen
Yuyu Xiong
Xi Wu
Jiamin Niu
Xia Han
Zhengan Tian
Lun Yang
Guoyin Feng
Lin He
Shengying Qin
spellingShingle Ran Huo
Kefu Tang
Zhiyun Wei
Lu Shen
Yuyu Xiong
Xi Wu
Jiamin Niu
Xia Han
Zhengan Tian
Lun Yang
Guoyin Feng
Lin He
Shengying Qin
Genetic polymorphisms in CYP2E1: association with schizophrenia susceptibility and risperidone response in the Chinese Han population.
PLoS ONE
author_facet Ran Huo
Kefu Tang
Zhiyun Wei
Lu Shen
Yuyu Xiong
Xi Wu
Jiamin Niu
Xia Han
Zhengan Tian
Lun Yang
Guoyin Feng
Lin He
Shengying Qin
author_sort Ran Huo
title Genetic polymorphisms in CYP2E1: association with schizophrenia susceptibility and risperidone response in the Chinese Han population.
title_short Genetic polymorphisms in CYP2E1: association with schizophrenia susceptibility and risperidone response in the Chinese Han population.
title_full Genetic polymorphisms in CYP2E1: association with schizophrenia susceptibility and risperidone response in the Chinese Han population.
title_fullStr Genetic polymorphisms in CYP2E1: association with schizophrenia susceptibility and risperidone response in the Chinese Han population.
title_full_unstemmed Genetic polymorphisms in CYP2E1: association with schizophrenia susceptibility and risperidone response in the Chinese Han population.
title_sort genetic polymorphisms in cyp2e1: association with schizophrenia susceptibility and risperidone response in the chinese han population.
publisher Public Library of Science (PLoS)
series PLoS ONE
issn 1932-6203
publishDate 2012-01-01
description CYP2E1 is a member of the cytochrome P450 superfamily, which is involved in the metabolism and activation of both endobiotics and xenobiotics. The genetic polymorphisms of CYP2E1 gene (Chromosome 10q26.3, Accession Number NC_000010.10) are reported to be related to the development of several mental diseases and to be involved in the clinical efficacy of some psychiatric medications. We investigated the possible association of CYP2E1 polymorphisms with susceptibility to schizophrenia in the Chinese Han Population as well as the relationship with response to risperidone in schizophrenia patients.In a case-control study, we identified 11 polymorphisms in the 5' flanking region of CYP2E1 in 228 schizophrenia patients and 384 healthy controls of Chinese Han origin. From among the cases, we chose 130 patients who had undergone 8 weeks of risperidone monotherapy to examine the relationship between their response to risperidone and CYP2E1 polymorphisms. Clinical efficacy was assessed using the Brief Psychiatric Rating Scale (BPRS).Statistically significant differences in allele or genotype frequencies were found between cases and controls at rs8192766 (genotype p = 0.0048, permutation p = 0.0483) and rs2070673 (allele: p = 0.0018, permutation p = 0.0199, OR = 1.4528 95%CI = 1.1487-1.8374; genotype: p = 0.0020, permutation p = 0.0225). In addition, a GTCAC haplotype containing 5 SNPs (rs3813867, rs2031920, rs2031921, rs3813870 and rs2031922) was observed to be significantly associated with schizophrenia (p = 7.47E-12, permutation p<0.0001). However, no association was found between CYP2E1 polymorphisms/haplotypes and risperidone response.Our results suggest that CYP2E1 may be a potential risk gene for schizophrenia in the Chinese Han population. However, polymorphisms of the CYP2E1 gene may not contribute significantly to individual differences in the therapeutic efficacy of risperidone. Further studies in larger groups are warranted to confirm our results.
url http://europepmc.org/articles/PMC3350493?pdf=render
work_keys_str_mv AT ranhuo geneticpolymorphismsincyp2e1associationwithschizophreniasusceptibilityandrisperidoneresponseinthechinesehanpopulation
AT kefutang geneticpolymorphismsincyp2e1associationwithschizophreniasusceptibilityandrisperidoneresponseinthechinesehanpopulation
AT zhiyunwei geneticpolymorphismsincyp2e1associationwithschizophreniasusceptibilityandrisperidoneresponseinthechinesehanpopulation
AT lushen geneticpolymorphismsincyp2e1associationwithschizophreniasusceptibilityandrisperidoneresponseinthechinesehanpopulation
AT yuyuxiong geneticpolymorphismsincyp2e1associationwithschizophreniasusceptibilityandrisperidoneresponseinthechinesehanpopulation
AT xiwu geneticpolymorphismsincyp2e1associationwithschizophreniasusceptibilityandrisperidoneresponseinthechinesehanpopulation
AT jiaminniu geneticpolymorphismsincyp2e1associationwithschizophreniasusceptibilityandrisperidoneresponseinthechinesehanpopulation
AT xiahan geneticpolymorphismsincyp2e1associationwithschizophreniasusceptibilityandrisperidoneresponseinthechinesehanpopulation
AT zhengantian geneticpolymorphismsincyp2e1associationwithschizophreniasusceptibilityandrisperidoneresponseinthechinesehanpopulation
AT lunyang geneticpolymorphismsincyp2e1associationwithschizophreniasusceptibilityandrisperidoneresponseinthechinesehanpopulation
AT guoyinfeng geneticpolymorphismsincyp2e1associationwithschizophreniasusceptibilityandrisperidoneresponseinthechinesehanpopulation
AT linhe geneticpolymorphismsincyp2e1associationwithschizophreniasusceptibilityandrisperidoneresponseinthechinesehanpopulation
AT shengyingqin geneticpolymorphismsincyp2e1associationwithschizophreniasusceptibilityandrisperidoneresponseinthechinesehanpopulation
_version_ 1724812681093840896